Delivery Order SPE2DB22D1017-SPE2DB24FE9YA
Award Date
12/15/23
Potential Completion Date
12/18/23
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,102.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,012.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is January 24, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,273.82, is for the delivery of Fluticasone Propionate HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,592.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a period of performance through April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.18 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 mcg 12 gm, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,428.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and uses a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,271.70, is for the delivery of Fluticasone Propionate HFA 44 MCG 10.6GM, a medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,667.32, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 31, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,145.19 and an ultimate completion date of May 21, 2024. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,358.22 firm fixed price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...